Botanical species · safety record

Artemisia pontica

The EFSA Compendium of Botanicals holds 24 constituent measurements and 2 adverse-effect records for Artemisia pontica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia pontica L.

24Constituent measurements

2Safety records

13Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-camphor	Aerial part of plants	Essential oil	16 Percent	GC-MS (Q)	Resolve DOI
(-)-camphor	Aerial part of plants	Solvent extraction	13.9 Percent	GC-MS	Resolve DOI
1,8-cineole	Aerial part of plants	Solvent extraction	14.1 Percent	GC-MS	Resolve DOI
1,8-cineole	Aerial part of plants	Essential oil	≥ 12 Percent	Unspecified	Resolve DOI
Alpha-terthienyl	Aerial part of plants	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Alpha-thujone	Aerial part of plants	Essential oil	23.2 Percent	GC-MS (Q)	Resolve DOI
Beta-thujone	Aerial part of plants	Essential oil	2.7 Percent	GC-MS (Q)	Resolve DOI
Cis-piperitone epoxide	Aerial part of plants	Essential oil	1.2 Percent	GC-MS (Q)	Resolve DOI
Germacranolide	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Isofraxidin	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Sesquiterpene lactones	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Sesquiterpene lactones	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
1,8-cineole	Aerial part of plants	Essential oil	—	GC-MS	No resolvable identifier
1,8-cineole	Aerial part of plants	Essential oil	< 20 Percent Area	GC-MS	No resolvable identifier
1,8-cineole	Aerial part of plants	Essential oil	< 70.6 Percent	GC-MS	No resolvable identifier
1,8-cineole	Aerial part of plants	Essential oil	12 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Alpha-thujone	Aerial part of plants	Essential oil	—	GC-MS	No resolvable identifier
Alpha-thujone	Aerial part of plants	Essential oil	30 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Artemisia ketone	Aerial part of plants	Essential oil	47 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Camphor	Aerial part of plants	Essential oil	< 27.4 Percent	GC-MS	No resolvable identifier
Camphor	Aerial part of plants	Essential oil	> 50 Percent Area	GC-MS	No resolvable identifier
Estragole	Aerial part of plants	Essential oil	—	GC-MS	No resolvable identifier
Pinocarvone	Aerial part of plants	Essential oil	> 3 Percent Area	GC-MS	No resolvable identifier
Santonin	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Other toxicities	Liver	Aerial part of plants	Essential oil (as part-nature)	Rat (as animal)	Short-term toxicity	Resolve DOI
Other toxicities	Neurologic: central nervous system	Aerial part of plants	Solvent extraction	Human (as organism)	Short-term toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Talzhanov, NA., Sadyrbekov, DT., Smagulova, FM., Mukanov, RM., Raldugin, VA., Shakirov, MM., Tkachev, AV., Atazhanova, GA., Tuleuov, BI., Adekenov, SM. Components OF Artemisia pontica. Chemistry of natural compounds, 2005, vol. 41, no. 2, p. 178-181. DOI
Nano, Gian M., Martelli, Aldo., Sancin, Peter. Chemical investigations of Artemisia grown in Piedmont. Rivista italiana essenze, profumi, piante officinali, aromi, saponi, cosmetici, aerosol, 1966, vol. 98, no. 7, p. 409-12.
Bos, R., Stojanova, AS., Woerdenbag, HJ., Koulman, A., Quax, WJ. Volatile components of the aerial parts of Artemisia pontica L. grown in Bulgaria . Flavour and fragrance journal, 2005, vol. 20, no. 2, p. 145-148. DOI
Khanina, M. A., Serykh, E. A., Korolyuk, A. Yu., Bel'chenko, L. A., Pokrovsky, L. M., Tkachev, A. V. Composition of essential oil of Siberian populations of Artemisia pontica L. - as a promising medicinal plant. Khimiya rastitel'nogo syr'ya, 2000, vol. (3), p. 85-94.
Makarova, D. L., Khanina, M. A., Amel'chenko, V. P., Domrachev, D. V., Tkachev, A. V. Chemical study of essential oil of Artemisia pontica L. from Siberia. Khimiya rastitel'nogo syr'ya, 2008, vol. (2), p. 55-60.
TOSI, B., BONORA, A., DALLOLIO, G., BRUNI, A. SCREENING FOR TOXIC THIOPHENE COMPOUNDS FROM CRUDE DRUGS OF THE FAMILY COMPOSITAE USED IN NORTHERN ITALY . Phytotherapy research, 1991, vol. 5, no. 2, p. 59-62. DOI
ARNOLD, WN., DALTON, TP., LOFTUS, LS., CONAN, PA. A SEARCH FOR SANTONIN IN ARTEMISIA-PONTICA, THE OTHER WORMWOOD OF OLD ABSINTHE . Journal of chemical education, 1991, vol. 68, no. 1, p. 27-28.
Talzhanov, NA., Mukanov, RM., Raldugin, VA., Shakirov, MM., Atazhanova, GA., Adekenov, SM. Dihydroridentin from Artemisia pontica and its stereochemistry. Chemistry of natural compounds, 2005, vol. 41, no. 4, p. 423-425. DOI
Todorova, MN., Tsankova, ET., Trendafilova, AB., Gussev, CV. Sesquiterpene lactones with the uncommon rotundane skeleton from Artemisia pontica L. . Phytochemistry, 1996, vol. 41, no. 2, p. 553-556. DOI
Trendafilova, AB., Todorova, MN., Gussev, CV. Eudesmanolides from Artemisia pontica. Phytochemistry, 1996, vol. 42, no. 2, p. 469-471. DOI
GREGER, H., HOFER, O., NIKIFOROV, A. NEW SESQUITERPENE-COUMARIN ETHERS FROM ACHILLEA AND ARTEMISIA SPECIES. Journal of natural products, 1982, vol. 45, no. 4, p. 455-461. DOI
HURABIELLE, M., TILLEQUIN, F., PARIS, M. CHEMICAL STUDY OF ARTEMISIA-PONTICA ESSENTIAL OIL. Planta medica, 1977, vol. 31, no. 2, p. 97-102.
De Vincenzi, M., Silano, M., De Vincenzi, A., Maialetti, F., Scazzocchio, B. Constituents of aromatic plants: eucalyptol. Fitoterapia, 2002, vol. 73, no. 3, p. 269-275. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature